Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm
Clinical trial NCT03462641 · COMPLETED
Trial details
- NCT number
- NCT03462641
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2021-06-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.